Hyporexia and weight loss are important indicators of physical and psychological well‐being in macaque colonies. An FDA‐approved transdermal formulated Mirtazapine (MTZ) shows effectiveness in managing feline hyporexia. This study sought to determine its effectiveness as an appetite stimulant in macaques.

中文翻译：

---

透皮米氮平对缺氧恒河猴和食蟹猴（Macaca mulatta 和 Macaca fascicularis）的影响

缺氧和体重减轻是猕猴群体身心健康的重要指标。FDA 批准的透皮配方米氮平 (MTZ) 显示出治疗猫缺食症的有效性。这项研究试图确定其作为猕猴食欲兴奋剂的有效性。